Second case of ranitidine-related toxic epidermal necrolysis in a patient with idiopathic thrombocytopenic purpura.
Vélez
A
A
Moreno
J C
JC
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D005260:Female; D005440:Fluid Therapy; D006635:Histamine H2 Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D011899:Ranitidine / Q000009:adverse effects* / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000209:etiology* / Q000473:pathology
D000890:Anti-Infective Agents; D006635:Histamine H2 Antagonists; D002939:Ciprofloxacin; D011899:Ranitidine